{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:07:28Z","timestamp":1794013648286,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","award":["2022-FIRE-004-Pallauf"],"award-info":[{"award-number":["2022-FIRE-004-Pallauf"]}],"id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euo.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:44:55Z","timestamp":1789847095000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated Urine and Plasma DNA Analysis for Molecular Staging of Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","author":[{"given":"Maximilian","family":"Pallauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Bronimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Rapiey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-4586","authenticated-orcid":false,"given":"Vincent T.","family":"Bicocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"McConkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-6983","authenticated-orcid":false,"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.08.008_b0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0010","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.3390\/cancers15205040","article-title":"Imaging in upper tract urothelial carcinoma: a review","volume":"15","author":"Tsikitas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2026.08.008_b0015","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejso.2020.06.024","article-title":"Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis","volume":"46","author":"Subiela","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.euo.2026.08.008_b0020","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2018.02.002","article-title":"Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma","volume":"199","author":"Margolin","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0025","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.08.008_b0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0035","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter Phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.08.008_b0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.eururo.2025.08.012","article-title":"Neoadjuvant chemotherapy for high-risk localized upper tract urothelial carcinoma: final long-term outcomes from a Phase 2 clinical trial and an expanded cohort","volume":"89","author":"Jayalath","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2023.09.017","article-title":"Novel use of circulating tumor DNA to identify muscle-invasive and non\u2013organ-confined upper tract urothelial carcinoma","volume":"85","author":"Huelster","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fruro.2023.1229709","article-title":"Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report","volume":"3","author":"Yonover","year":"2023","journal-title":"Front Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0055","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1158\/1078-0432.CCR-23-0570","article-title":"Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk-prediction","volume":"29","author":"Salari","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2026.08.008_b0060","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-23-0513","article-title":"Urinary tumor DNA MRD analysis to identify responders to neoadjuvant immunotherapy in muscle-invasive bladder cancer","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2026.08.008_b0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2025.03.023","article-title":"Urine tumor DNA to stratify the risk of recurrence in patients treated with atezolizumab for Bacillus Calmette-Gu\u00e9rin\u2013unresponsive non\u2013muscle-invasive bladder cancer","volume":"88","author":"St-Laurent","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euo.2024.09.016","article-title":"Minimal residual disease detection with urine-derived DNA is prognostic for recurrence-free survival in Bacillus Calmette-Gu\u00e9rin\u2013unresponsive non\u2013muscle-invasive bladder cancer treated with Nadofaragene Firadenovec","volume":"8","author":"Narayan","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.08.008_b0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2020.05.039","article-title":"Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: a systematic review of the current literature","volume":"78","author":"Hassler","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euf.2018.01.003","article-title":"Grading of urothelial carcinoma and the new \u201cWorld Health Organisation classification of tumours of the urinary system and male genital organs 2016.","volume":"5","author":"Comp\u00e9rat","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.08.008_b0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.annpat.2023.12.010","article-title":"The Paris system, 2022 edition: What is new?","volume":"44","author":"Courtade-Sa\u00efdi","year":"2024","journal-title":"Ann Pathol"},{"key":"10.1016\/j.euo.2026.08.008_b0095","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.3390\/jcm11195827","article-title":"Urinary comprehensive genomic profiling correlates urothelial carcinoma mutations with clinical risk and efficacy of intervention","volume":"11","author":"Bicocca","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.euo.2026.08.008_b0100","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/sim.5587","article-title":"A weighted generalized score statistic for comparison of predictive values of diagnostic tests","volume":"32","author":"Kosinski","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.euo.2026.08.008_b0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0115","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2026.08.008_b0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2026.08.008_b0125","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41467-020-15885-7","article-title":"Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2026.08.008_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13059-020-02230-w","article-title":"Comprehensive integrative profiling of upper tract urothelial carcinomas","volume":"22","author":"Su","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.euo.2026.08.008_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2026.08.008_b0140","article-title":"Genomic landscape and clinical relevance in Chinese patients with upper tract urothelial carcinoma","volume":"9","author":"Shang","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.euo.2026.08.008_b0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.euf.2021.05.002","article-title":"Accuracy and clinical utility of a tumor grade- and stage-based predictive model in localized upper tract urothelial carcinoma","volume":"8","author":"Katayama","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.08.008_b0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/iju.13032","article-title":"Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma","volume":"23","author":"Jinzaki","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.08.008_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.urology.2020.09.036","article-title":"Complications associated with ureteroscopic management of upper tract urothelial carcinoma","volume":"147","author":"Linehan","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.08.008_b0165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00345-019-02891-8","article-title":"Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications","volume":"38","author":"Baboudjian","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00345-016-1909-0","article-title":"Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study","volume":"35","author":"Somani","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0175","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","article-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel","volume":"70","author":"Seisen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.08.008_b0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/curroncol29020060","article-title":"Current advances in immune checkpoint inhibition and clinical genomics in upper tract urothelial carcinoma: state of the art","volume":"29","author":"Califano","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.euo.2026.08.008_b0185","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMoa2511674","article-title":"Perioperative enfortumab vedotin and pembrolizumab in bladder cancer","volume":"394","author":"Vulsteke","year":"2026","journal-title":"N Engl J Med"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:11:49Z","timestamp":1789935109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S2588931126002385"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.08.008","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Urine and Plasma DNA Analysis for Molecular Staging of Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}